Recurrent neural networks for generalization towards the vessel geometry in autonomous endovascular guidewire navigation in the aortic arch - Top-Institutions - MDSpire

Recurrent neural networks for generalization towards the vessel geometry in autonomous endovascular guidewire navigation in the aortic arch

  • By

  • Lennart Karstensen

  • Jacqueline Ritter

  • Johannes Hatzl

  • Floris Ernst

  • Jens Langejürgen

  • Christian Uhl

  • Franziska Mathis-Ullrich

  • May 28, 2023

  • 0 min

Share

Top Institutions in Surgery

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Interventional Radiology
    • Biomedical Engineering
    • Artificial Intelligence in Medicine

  • #2

    Stanford University Medical Center
    Stanford University Medical Center

    Stanford, CA

    Key Differentiators

    • Interventional Radiology
    • Biomedical Informatics
    • Robotics

  • #3

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Interventional Radiology
    • Neuroradiology
    • Medical Imaging

  • #4

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Interventional Neuroradiology
    • Biomedical Engineering
    • AI in Medicine

  • #5

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Vascular Surgery
    • Interventional Radiology
    • Medical Robotics

Original Source(s)

Recurrent neural networks for generalization towards the vessel geometry in autonomous endovascular guidewire navigation in the aortic arch

  • by Lennart Karstensen, Jacqueline Ritter, Johannes Hatzl, Floris Ernst, Jens Langejürgen, Christian Uhl, Franziska Mathis-Ullrich

  • May 28, 2023

Related Content

Amputation Rates Rose in Opioid-Related Hospitalizations

National inpatient analysis found steeper increases in amputations during opioid-related hospitalizations, particularly in the Northeast and West.

AI Scribes: Efficiency for Whom?

Unresolved safety, privacy, and regulatory concerns may limit benefits of AI scribes for physicians and patients.

Retatrutide Shows 28% Weight Loss in Phase 3 Trial

Nearly half of participants receiving the highest dose achieved at least 30% body weight reduction.